Clinical Trial

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Name: Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy — clinical trial record (NCT07336797)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

We investigate the role of empagliflozin in the treatment of obesity in PLWH.

Trial Details

NCT Number	NCT07336797
Lead Sponsor	Abdelrahman Mahmoud
Conditions	Metabolic Syndrome, Obesity & Overweight, HIV (Human Immunodeficiency Virus)
Enrollment	66 participants
Start Date	2025-09-01
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-13